Tazeen Ahmad

Stock Analyst at B of A Securities

(3.35)
# 1,006
Out of 4,989 analysts
211
Total ratings
47.44%
Success rate
3.24%
Average return

Stocks Rated by Tazeen Ahmad

Alnylam Pharmaceuticals
Sep 17, 2025
Maintains: Buy
Price Target: $453$520
Current: $454.41
Upside: +14.43%
Incyte
Sep 4, 2025
Maintains: Buy
Price Target: $90$104
Current: $84.54
Upside: +23.02%
Ascendis Pharma
Sep 2, 2025
Maintains: Buy
Price Target: $227$230
Current: $193.98
Upside: +18.57%
argenx SE
Sep 2, 2025
Maintains: Buy
Price Target: $880$887
Current: $734.39
Upside: +20.78%
Sarepta Therapeutics
Aug 21, 2025
Maintains: Underperform
Price Target: $17$16
Current: $17.93
Upside: -10.76%
PTC Therapeutics
Aug 20, 2025
Maintains: Buy
Price Target: $82$76
Current: $60.56
Upside: +25.50%
BioNTech SE
Aug 5, 2025
Maintains: Buy
Price Target: $126$134
Current: $98.27
Upside: +36.36%
Apellis Pharmaceuticals
Jul 16, 2025
Maintains: Neutral
Price Target: $23$24
Current: $23.19
Upside: +3.49%
Taysha Gene Therapies
Jul 11, 2025
Initiates: Buy
Price Target: $8
Current: $2.92
Upside: +173.97%
Rhythm Pharmaceuticals
Jul 10, 2025
Maintains: Buy
Price Target: $73$95
Current: $98.70
Upside: -3.75%
Maintains: Buy
Price Target: $13$15
Current: $7.82
Upside: +91.82%
Maintains: Neutral
Price Target: $18$23
Current: $23.60
Upside: -2.54%
Downgrades: Underperform
Price Target: $22$4
Current: $8.31
Upside: -51.87%
Maintains: Underperform
Price Target: $1$0.8
Current: $0.83
Upside: -3.43%
Maintains: Buy
Price Target: $28$27
Current: $13.05
Upside: +106.90%
Maintains: Buy
Price Target: $54$28
Current: $7.53
Upside: +271.85%
Maintains: Buy
Price Target: $73$70
Current: $68.22
Upside: +2.61%
Maintains: Buy
Price Target: $42$40
Current: $7.61
Upside: +425.62%
Maintains: Buy
Price Target: $184$179
Current: $146.40
Upside: +22.27%
Initiates: Buy
Price Target: $22
Current: $13.02
Upside: +68.97%
Downgrades: Underperform
Price Target: $6$3
Current: $1.95
Upside: +53.85%
Maintains: Buy
Price Target: $13$15
Current: $8.16
Upside: +83.82%
Downgrades: Underperform
Price Target: $10$2
Current: $7.35
Upside: -72.79%
Maintains: Buy
Price Target: $83$76
Current: $28.40
Upside: +167.61%
Maintains: Buy
Price Target: $7$10
Current: $2.91
Upside: +243.64%
Maintains: Underperform
Price Target: $2$6
Current: $0.97
Upside: +518.49%
Initiates: Buy
Price Target: $15
Current: $12.25
Upside: +22.45%
Maintains: Underperform
Price Target: $8$11
Current: $24.90
Upside: -55.82%
Downgrades: Underperform
Price Target: $7$2
Current: $3.38
Upside: -40.83%
Downgrades: Underperform
Price Target: $6
Current: $1.03
Upside: +482.52%
Downgrades: Underperform
Price Target: $75$15
Current: $12.08
Upside: +24.17%
Downgrades: Neutral
Price Target: $390$60
Current: $48.60
Upside: +23.46%
Initiates: Neutral
Price Target: $16
Current: $2.19
Upside: +630.59%
Upgrades: Buy
Price Target: $43
Current: $14.74
Upside: +191.72%
Downgrades: Underperform
Price Target: n/a
Current: $204.03
Upside: -
Maintains: Buy
Price Target: $330$300
Current: $9.35
Upside: +3,108.56%
Downgrades: Underperform
Price Target: $19$9
Current: $2.00
Upside: +351.13%
Maintains: Neutral
Price Target: $46$48
Current: $26.21
Upside: +83.14%